Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Erleada
Manufacturing
J&J touts progress on new launches as Stelara cliff nears
Even after touting third-quarter revenue and profit growth, Johnson & Johnson is busy getting ready for the looming Stelara loss of exclusivity.
Eric Sagonowsky
Oct 17, 2023 10:15am
J&J breaks out the blue jacket for prostate cancer awareness
Feb 7, 2023 7:35am
J&J kicks off prostate cancer health disparities campaign
Sep 21, 2022 9:25am
Bayer's Nubeqa nabbed a second prostate cancer indication
Aug 8, 2022 10:13am
Bayer wins priority review for prostate cancer drug Nubeqa
May 3, 2022 3:37pm
Bayer hikes Nubeqa's peak sales to over €3B amid 3-way battle
Feb 17, 2022 4:32pm